Clinical Trials Logo

Malignant Neoplasm clinical trials

View clinical trials related to Malignant Neoplasm.

Filter by:

NCT ID: NCT03895918 Completed - Malignant Neoplasm Clinical Trials

Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer Patients

Start date: January 3, 2019
Phase: N/A
Study type: Interventional

This trial studies how well a parenting skills intervention works in improving medication adherence in pediatric cancer patients. The parenting skills intervention provides support and skills training to parents who administer medicine daily to their child and may improve the childs taking of medications correctly as prescribed by the doctor. Ultimately, this may improve treatment outcomes, among children who are experiencing an illness.

NCT ID: NCT03867916 Completed - Malignant Neoplasm Clinical Trials

Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients

Start date: December 13, 2018
Phase: N/A
Study type: Interventional

This phase I/II trial studies how well patient portal and navigation program work in providing information for Asian American cancer patients. Patient portal and navigation program may help to improve the care provided to Asian American cancer patients.This study is offered in the following languages in addition to English: Chinese (Cantonese or Mandarin) and Vietnamese.

NCT ID: NCT03808870 Completed - Malignant Neoplasm Clinical Trials

A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Asian Patients With Advanced Cancer

Start date: December 28, 2018
Phase: Phase 1
Study type: Interventional

NBM-BMX is an orally available new chemical entity to inhibit HDAC8 activity specifically, being developed as a potential anti-cancer therapeutic by NatureWise. The objectives of this study are to evaluate the safety, pharmacokinetics, and preliminary efficacy of NBM-BMX as monotherapy in subjects with advanced solid tumors (Arm A) or in combination with the standard of care treatment (i.e., concomitant RT/TMZ followed by adjuvant TMZ) in subjects with newly diagnosed glioblastoma (Arm B).

NCT ID: NCT03808818 Completed - Malignant Neoplasm Clinical Trials

Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices

Start date: August 1, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well smoking cessation treatment plans work in tobacco-dependent cancer patients when delivered virtually as part of their cancer care in community oncology practices. Virtual information and counseling sessions may help cancer patients quit smoking.

NCT ID: NCT03747276 Completed - Malignant Neoplasm Clinical Trials

Can Electronic Information Kiosks Enhance Patient Accrual for Cancer Clinical Trials? A Pilot and Feasibility Study

Start date: July 19, 2018
Phase: N/A
Study type: Interventional

The proposed study will include patients with non-haematologic cancer. Eligible patients will be invited to consent for participation in our study using standard demographic data collection forms and patient satisfaction questionnaires. Cancer patients interested in learning more about clinical trials would be invited to go to the kiosk. A summer student approved and hired according to London Health Sciences Centre LHSC/Lawson criteria will be available from 0900-1630 daily for general assistance. If the student is overwhelmed by questions or numbers of patients, the Research Navigator or designate would be called to assist. An information kiosk will be placed at the patient library on the ground floor of the LRCP. This kiosk will be outfitted with a computer and signage briefly outlining the title and purpose of the kiosk. Cancer patients interested in learning more about clinical trials would be invited to participate in our study by signing a consent form allowing the Research Navigator to contact them if they expressed interest in knowing more about a clinical trial.

NCT ID: NCT03746392 Completed - Dementia Clinical Trials

Project to Improve Communication About Serious Illness - Pilot Study

PICSI-P
Start date: July 1, 2018
Phase: N/A
Study type: Interventional

This two-year pilot study will test whether a one-page "Jumpstart Form" will affect goals-of-care discussions in the hospital. This form will be provided to clinicians and will include patient-specific information about preferences for goals-of-care communication and for care, as well as tips to improve this communication. Jumpstart forms will also be provided to patients or, if they are unable to communicate, their surrogates/family members. The information on the form will be obtained from questionnaires. The form is tailored to help patients and surrogates talk with clinicians about goals of care. This study is based on a successful application of Jumpstart Form in the outpatient clinic setting.

NCT ID: NCT03726294 Completed - Malignant Neoplasm Clinical Trials

A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced Cancer

Start date: October 16, 2018
Phase: Phase 1
Study type: Interventional

NBM-BMX is a new small molecule chemical entity being developed as a potential anti-cancer therapeutic by NatureWise. NBM-BMX is a histone deacetylase (HDAC) inhibitor and has been shown to be particularly active against HDAC8. The objectives of this study are to determine the safety profile of NBM-BMX, including identification of dose limiting toxicity (DLT) and maximum tolerated dose (MTD), and to determine the Recommended Phase 2 Dose (RP2D).

NCT ID: NCT03685539 Completed - Malignant Neoplasm Clinical Trials

DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis

Start date: August 24, 2018
Phase: N/A
Study type: Interventional

This trial studies how well dual energy computed tomography (DECT) works in imaging patients with solid organ cancer that has spread to the brain. Imaging techniques, such as DECT, may help find and diagnose tumor cells and find out how far the tumor cells have spread in the brain.

NCT ID: NCT03683420 Completed - Malignant Neoplasm Clinical Trials

Music in Reducing Distress in Participants With Cancer During Chemotherapy Treatment

Start date: February 14, 2018
Phase: N/A
Study type: Interventional

This trial studies how well music works in reducing distress in participants with cancer during chemotherapy treatment. Music in participants receiving cancer treatment such as infusion treatment and caregiver may reduce pain, anxiety, and distress and improve participant's psychological and physiological wellbeing.

NCT ID: NCT03679585 Completed - Malignant Neoplasm Clinical Trials

Talking Pictures Social Media Intervention in Reducing Depressive Symptoms and Improving Spiritual Well-Being and Quality of Life in Adolescent and Young Adult Cancer Patients

Start date: May 31, 2017
Phase: N/A
Study type: Interventional

This clinical trial studies how well Talking Pictures social media intervention works in reducing depressive symptoms and improving spiritual well-being and quality of life in adolescent and young adult cancer patients. Talking Pictures social media intervention may help doctors better learn how to most effectively provide psychosocial support to adolescent and young adult cancer patients.